These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32450122)

  • 1. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
    Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
    Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
    Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
    BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study.
    O'Grady KA; Lee KJ; Carlin JB; Torzillo PJ; Chang AB; Mulholland EK; Lambert SB; Andrews RM
    Clin Infect Dis; 2010 Apr; 50(7):970-8. PubMed ID: 20192729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
    Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalisation of Indigenous children in the Northern Territory for lower respiratory illness in the first year of life.
    O'Grady KA; Torzillo PJ; Chang AB
    Med J Aust; 2010 May; 192(10):586-90. PubMed ID: 20477735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of Australia.
    Binks MJ; Moberley SA; Balloch A; Leach AJ; Nelson S; Hare KM; Wilson C; Nelson J; Morris PS; Ware RS; Tang MLK; Torzillo PJ; Carapetis JR; Mulholland K; Andrews RM
    Pneumonia (Nathan); 2018; 10():13. PubMed ID: 30603376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pneumococcal conjugate vaccines on incidence and microbiology associated with complicated acute otitis media.
    Laursen BB; Danstrup CS; Hoffmann S; Nørskov-Lauritsen N; Christensen ALB; Ovesen T
    Int J Pediatr Otorhinolaryngol; 2017 Oct; 101():249-253. PubMed ID: 28964304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
    Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
    Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective cohort study investigating the comparative effectiveness of pneumococcal vaccines against hospitalisation with otitis media and pneumonia in New Zealand.
    Paynter J; Howe AS; Best E; Petousis-Harris H
    Vaccine; 2023 Jun; 41(28):4121-4128. PubMed ID: 37244807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children.
    Mezones-Holguín E; Bolaños-Díaz R; Fiestas V; Sanabria C; Gutiérrez-Aguado A; Fiestas F; Suárez VJ; Rodriguez-Morales AJ; Hernández AV
    J Infect Dev Ctries; 2014 Dec; 8(12):1552-62. PubMed ID: 25500653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of pneumococcal conjugate vaccine coverage and indirect protection against invasive pneumococcal disease and pneumonia hospitalisations in Australia: An observational study.
    Chan J; Gidding HF; Blyth CC; Fathima P; Jayasinghe S; McIntyre PB; Moore HC; Mulholland K; Nguyen CD; Andrews R; Russell FM
    PLoS Med; 2021 Aug; 18(8):e1003733. PubMed ID: 34343186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years.
    Greenberg D; Givon-Lavi N; Ben-Shimol S; Ziv JB; Dagan R
    Vaccine; 2015 Aug; 33(36):4623-9. PubMed ID: 26116251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old.
    Reyburn R; Tsatsaronis A; von Mollendorf C; Mulholland K; Russell FM;
    J Glob Health; 2023 Feb; 13():05002. PubMed ID: 36734192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ten-valent pneumococcal conjugate vaccine introduction on pneumonia hospital admissions in Fiji: a time-series analysis.
    Reyburn R; Tuivaga E; Nguyen CD; Ratu FT; Nand D; Kado J; Tikoduadua L; Jenkins K; de Campo M; Kama M; Devi R; Rafai E; Weinberger DM; Mulholland EK; Russell FM
    Lancet Glob Health; 2021 Jan; 9(1):e91-e98. PubMed ID: 33227258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Pneumococcal Vaccination on Bacterial and Viral Pneumonia in Western Australian Children: Record Linkage Cohort Study of 469589 Births, 1996-2012.
    Fathima P; Blyth CC; Lehmann D; Lim FJ; Abdalla T; de Klerk N; Moore HC
    Clin Infect Dis; 2018 Mar; 66(7):1075-1085. PubMed ID: 29069315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine.
    Georgalis L; Mozalevskis A; Martínez de Aragón MV; Garrido-Estepa M
    Eur J Clin Microbiol Infect Dis; 2017 Mar; 36(3):575-583. PubMed ID: 27844262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine.
    Hsiao A; Hansen J; Timbol J; Lewis N; Isturiz R; Alexander-Parrish R; McLaughlin JM; Gessner BD; Klein NP
    JAMA Netw Open; 2022 Mar; 5(3):e221111. PubMed ID: 35302634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the introduction of pneumococcal conjugate vaccination on pneumonia in The Gambia: population-based surveillance and case-control studies.
    Mackenzie GA; Hill PC; Sahito SM; Jeffries DJ; Hossain I; Bottomley C; Uchendu U; Ameh D; Ndiaye M; Osuorah CD; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Ahameefula E; Muhammad BS; Fombah AE; Saha D; Mackenzie R; Plumb I; Akano A; Ebruke B; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UNA; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Sowe D; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
    Lancet Infect Dis; 2017 Sep; 17(9):965-973. PubMed ID: 28601421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased number of hospitalized children with severe acute lower respiratory infection after introduction of the pneumococcal conjugate vaccine in the Eastern Democratic Republic of the Congo.
    Birindwa AM; Manegabe JT; Mindja A; Nordén R; Andersson R; Skovbjerg S
    Pan Afr Med J; 2020; 37():211. PubMed ID: 33520050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.